National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Drug Information
Page Options
Print This Page
E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
Quit Smoking Today
NCI Highlights
Report to Nation Finds Declines in Cancer Incidence, Death Rates

High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

The Nation's Investment in Cancer Research FY 2009

Past Highlights
Drug Information Summaries

NCI's drug information summaries provide consumer-friendly information about certain drugs that are approved by the U.S. Food and Drug Administration (FDA) to treat cancer or conditions related to cancer. For each drug, topics covered include background, research results, possible side effects, approval information, and ongoing clinical trials.

The alphabetical list of drug information summaries includes brand and generic drug names. For each brand name, the generic name is shown in parentheses: Brand name (Generic).

Alphabetical List of Drug Information Summaries

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z 
A
Abitrexate (Methotrexate)
Abraxane (Paclitaxel Albumin-stabilized Nanoparticle Formulation)
Adriamycin (Doxorubicin Hydrochloride)
Adrucil (Fluorouracil)
Aldara (Imiquimod)
Aldesleukin
Alemtuzumab
Alimta (Pemetrexed Disodium)
Aminolevulinic Acid
Anastrozole
Aprepitant
Arimidex (Anastrozole)
Aromasin (Exemestane)
Arranon (Nelarabine)
Arsenic Trioxide
Avastin (Bevacizumab)
Azacitidine
B
Bendamustine Hydrochloride
Bevacizumab
Bexarotene
Bexxar (Tositumomab and I 131 Iodine Tositumomab)
Bortezomib
C
Campath (Alemtuzumab)
Camptosar (Irinotecan Hydrochloride)
Capecitabine
Carboplatin
Cetuximab
Cisplatin
Clafen (Cyclophosphamide)
Clofarabine
Clofarex (Clofarabine)
Clolar (Clofarabine)
Cyclophosphamide
Cytarabine
Cytosar-U (Cytarabine)
Cytoxan (Cyclophosphamide)
D
Dacogen (Decitabine)
Dasatinib
Decitabine
Degarelix
DepoCyt (Liposomal Cytarabine)
DepoFoam (Liposomal Cytarabine)
Dexrazoxane Hydrochloride
Docetaxel
Doxil (Doxorubicin Hydrochloride Liposome)
Doxorubicin Hydrochloride
Doxorubicin Hydrochloride Liposome
Dox-SL (Doxorubicin Hydrochloride Liposome)
E
Efudex (Fluorouracil)
Eligard (Leuprolide Acetate)
Ellence (Epirubicin Hydrochloride)
Eloxatin (Oxaliplatin)
Eltrombopag Olamine
Emend (Aprepitant)
Epirubicin Hydrochloride
Erbitux (Cetuximab)
Erlotinib Hydrochloride
Etopophos (Etoposide Phosphate)
Etoposide
Etoposide Phosphate
Evacet (Doxorubicin Hydrochloride Liposome)
Evista (Raloxifene Hydrochloride)
Exemestane
F
Faslodex (Fulvestrant)
Femara (Letrozole)
Folex (Methotrexate)
Folex PFS (Methotrexate)
Fludara (Fludarabine Phosphate)
Fludarabine Phosphate
Fluoroplex (Fluorouracil)
Fluorouracil
Fulvestrant
G
Gefitinib
Gemcitabine Hydrochloride
Gemtuzumab Ozogamicin
Gemzar (Gemcitabine Hydrochloride)
Gleevec (Imatinib Mesylate)
H
Herceptin (Trastuzumab)
Hycamtin (Topotecan Hydrochloride)
I
Ibritumomab Tiuxetan
Imatinib Mesylate
Imiquimod
Iressa (Gefitinib)
Irinotecan Hydrochloride
Ixabepilone
Ixempra (Ixabepilone)
J
[No Entries]
K
Keoxifene (Raloxifene Hydrochloride)
Kepivance (Palifermin)
L
Lapatinib Ditosylate
Lenalidomide
Letrozole
Leucovorin Calcium
Leuprolide Acetate
Levulan (Aminolevulinic Acid)
LipoDox (Doxorubicin Hydrochloride Liposome)
Liposomal Cytarabine
Lupron (Leuprolide Acetate)
Lupron Depot (Leuprolide Acetate)
Lupron Depot-Ped (Leuprolide Acetate)
Lupron Depot-3 Month (Leuprolide Acetate)
Lupron Depot-4 Month (Leuprolide Acetate)
M
Methazolastone (Temozolomide)
Methotrexate
Methotrexate LPF (Methotrexate)
Mexate (Methotrexate)
Mexate-AQ (Methotrexate)
Mozobil (Plerixafor)
Mylosar (Azacitidine)
Mylotarg (Gemtuzumab Ozogamicin)
N
Nanoparticle Paclitaxel (Paclitaxel Albumin-stabilized Nanoparticle Formulation)
Nelarabine
Neosar (Cyclophosphamide)
Nexavar (Sorafenib Tosylate)
Nilotinib
Nolvadex (Tamoxifen Citrate)
Nplate (Romiplostim)
O
Oncaspar (Pegaspargase)
Oxaliplatin
P
Paclitaxel
Paclitaxel Albumin-stabilized Nanoparticle Formulation
Palifermin
Panitumumab
Paraplat (Carboplatin)
Paraplatin (Carboplatin)
Pegaspargase
Pemetrexed Disodium
Platinol-AQ (Cisplatin)
Platinol (Cisplatin)
Plerixafor
Proleukin (Aldesleukin)
Promacta (Eltrombopag Olamine)
Q
[No Entries]
R
Raloxifene Hydrochloride
Revlimid (Lenalidomide)
Rheumatrex (Methotrexate)
Rituxan (Rituximab)
Rituximab
Romiplostim
S
Sclerosol Intrapleural Aerosol (Talc)
Sorafenib Tosylate
Sprycel (Dasatinib)
Sterile Talc Powder (Talc)
Steritalc (Talc)
Sunitinib Malate
Sutent (Sunitinib Malate)
Synovir (Thalidomide)
T
Talc
Tamoxifen Citrate
Tarabine PFS (Cytarabine)
Tarceva (Erlotinib Hydrochloride)
Targretin (Bexarotene)
Tasigna (Nilotinib)
Taxol (Paclitaxel)
Taxotere (Docetaxel)
Temodar (Temozolomide)
Temozolomide
Temsirolimus
Thalomid (Thalidomide)
Thalidomide
Toposar (Etoposide)
Topotecan Hydrochloride
Totect (Dexrazoxane Hydrochloride)
Torisel (Temsirolimus)
Tositumomab and I 131 Iodine Tositumomab
Trastuzumab
Treanda (Bendamustine Hydrochloride)
Trisenox (Arsenic Trioxide)
Tykerb (Lapatinib Ditosylate)
U
[No Entries]
V
Vectibix (Panitumumab)
Velcade (Bortezomib)
VePesid (Etoposide)
Viadur (Leuprolide Acetate)
Vidaza (Azacitidine)
Vorinostat
Vincasar PFS (Vincristine Sulfate)
Vincristine Sulfate
W
Wellcovorin (Leucovorin Calcium)
X
Xeloda (Capecitabine)
Y
[No Entries]
Z
Zevalin (Ibritumomab Tiuxetan)
Zinecard (Dexrazoxane Hydrochloride)
Zoledronic Acid
Zolinza (Vorinostat)
Zometa (Zoledronic Acid)

Back to Top


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov